PGLYRP3 and neoplasm: Finally, PGLYRP3, GAL, ADCYAP1R1 and LIF (Fig. 3g) were selected to construct the Tumor Mutation Burden Immune Prognostic model (TMB-IP) using the following formula: TMB-IP score = (PGLYRP3*0.0988045135949462 + GAL*0.0483710471635067 + ADCYAP1R1*0.123387518699318 − LIF*0.121787959868336).